Ann: PharmAust appoints Sergio Duchini as Non-Executive Chairman, page-54

Yes I think we all know that someone could come forward with an offer at any time.
It's easy to sit on the side line and peruse for news and post that news.
PAA have already completed a phase 1 / 2 trial, obtained ODD designation and about to commence a phase 2 study.

They have 9 patients already started on extension study and wait on news of 2 remaining patient being dosed.

PAA have strong data that MPL is affective against cancer and strong clinical study data that suggests mpl could also be used to treat covid and could also be used for a number of other deseases.

They have finished a phase 2 canine cancer trial which improves both life style and extension of life.

If PAA want to either sell out or gain a partner moving forward this is what they need to be communicating, so instead of posting about other company's success how about he while still on the PAA payroll do something for PAA